BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $835 | -44.9% | 118,000 | -45.2% | 0.00% | 0.0% |
| Q2 2023 | $1,516 | +20.2% | 215,400 | +42.5% | 0.00% | 0.0% |
| Q1 2023 | $1,261 | -53.2% | 151,200 | -35.7% | 0.00% | -66.7% |
| Q4 2022 | $2,697 | -99.9% | 235,000 | -39.5% | 0.00% | -50.0% |
| Q3 2022 | $4,897,000 | +98.3% | 388,700 | +66.5% | 0.01% | +100.0% |
| Q2 2022 | $2,469,000 | -49.2% | 233,400 | -21.9% | 0.00% | -25.0% |
| Q1 2022 | $4,856,000 | +91.2% | 298,700 | +62.9% | 0.00% | +33.3% |
| Q4 2021 | $2,540,000 | -38.4% | 183,400 | -27.7% | 0.00% | -25.0% |
| Q3 2021 | $4,126,000 | +8.0% | 253,600 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $3,822,000 | – | 241,800 | +6605.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 3,606 | +552.1% | 0.00% | -100.0% |
| Q4 2020 | $411,000 | +1955.0% | 553 | +821.7% | 0.00% | – |
| Q3 2020 | $20,000 | -84.6% | 60 | -78.0% | 0.00% | – |
| Q2 2020 | $130,000 | +983.3% | 273 | +333.3% | 0.00% | – |
| Q1 2020 | $12,000 | +300.0% | 63 | +530.0% | 0.00% | – |
| Q4 2019 | $3,000 | -87.5% | 10 | -88.1% | 0.00% | – |
| Q3 2019 | $24,000 | -44.2% | 84 | -27.6% | 0.00% | – |
| Q2 2019 | $43,000 | -25.9% | 116 | +61.1% | 0.00% | – |
| Q1 2019 | $58,000 | +262.5% | 72 | +260.0% | 0.00% | – |
| Q4 2018 | $16,000 | -5.9% | 20 | -13.0% | 0.00% | – |
| Q3 2018 | $17,000 | +88.9% | 23 | +35.3% | 0.00% | – |
| Q2 2018 | $9,000 | – | 17 | +750.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 2 | -99.1% | 0.00% | – |
| Q4 2017 | $7,000 | -68.2% | 221 | -63.1% | 0.00% | -100.0% |
| Q3 2017 | $22,000 | +4.8% | 599 | +53.2% | 0.00% | 0.0% |
| Q2 2017 | $21,000 | -40.0% | 391 | -47.7% | 0.00% | -50.0% |
| Q1 2017 | $35,000 | -41.7% | 748 | +87.9% | 0.00% | -50.0% |
| Q4 2016 | $60,000 | +1400.0% | 398 | +234.5% | 0.00% | – |
| Q3 2016 | $4,000 | -71.4% | 119 | +17.8% | 0.00% | -100.0% |
| Q2 2016 | $14,000 | +366.7% | 101 | -13.7% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 117 | +74.6% | 0.00% | – |
| Q4 2015 | $2,000 | -96.6% | 67 | -84.9% | 0.00% | -100.0% |
| Q3 2015 | $59,000 | +436.4% | 444 | +788.0% | 0.00% | +300.0% |
| Q2 2015 | $11,000 | +175.0% | 50 | -63.2% | 0.00% | – |
| Q1 2015 | $4,000 | -90.7% | 136 | -39.0% | 0.00% | -100.0% |
| Q4 2014 | $43,000 | – | 223 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 772,100 | $6,439,314 | 0.02% |
| JANE STREET GROUP, LLC | 187,000 | $1,559,580 | 0.00% |
| SIMPLEX TRADING, LLC | 151,200 | $1,261 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |